An Open-Label, Observational, Prospective, Multicenter Study to Evaluate the Long-Term Efficacy and Safety of Perampanel as Monotherapy in Subjects Age 4 Years and Older with Focal Onset Seizures: PORTABLE Study First published 12/05/2025 Last updated 12/05/2025 EU PAS number:EUPAS1000000572 Study Ongoing